# DUPIXENT
> **BLA761055** · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2017-03-28
## Drug
- **FDA Application Number:** BLA761055
- **Application type:** Biologics License Application
- **Brand name:** DUPIXENT
- **Generic name:** DUPILUMAB
- **Active ingredients:** DUPILUMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** REGENERON PHARMACEUTICALS
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 2017-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761055)
---
*AI Analytics · CC0 1.0*